Hiroko Inazawa

Quantitative and Qualitative Differences in the In Vivo Response of NKT Cells to Distinct α- and β-Anomeric Glycolipids1

Jelena S. Bezbradica, Vrajesh V. Parekh, Michael T. Wilson, 2004, The Journal of Immunology.

CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells.

Tomoko Watanabe, I. Serizawa, Yasunori Uemura, 2006, Clinical immunology.

Anomeric Glycolipids β-and α Distinctthe In Vivo Response of NKT Cells to Quantitative and Qualitative Differences in

Jelena S. Bezbradica, Vrajesh V. Parekh, L. Kaer, 2004 .

Quantitative and qualitative differences in the in vivo response of NKT cells to distinct alpha- and beta-anomeric glycolipids.

Jelena S. Bezbradica, Vrajesh V. Parekh, Michael T. Wilson, 2004, Journal of immunology.